Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label crossover PK study of DS-8500a with atorvastatin in healthy Japanese subjects
jRCT2080222826Phase 1
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of firuglipel, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Effect of DS-8500a on atorvastatin pharmacokinetics.
02
Drugs
firuglipel
Beyond the preview
Go deeper on jRCT2080222826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222826.